1 active not recruiting, 1 completed, 1 recruiting, 1 unknown. 4 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 4 | Active not recruiting 1, Completed 1, Recruiting 1, Unknown 1 |
Follow Filoviridae Infections: new trials by email Literature Review of Filoviridae Infections trials Research Report on Filoviridae Infections
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| BRAVO is a Phased Outbreak-response Study in the DRC Evaluating ERVEBO® Vaccination in ~20,000 Frontline Workers During the 2026 BDV Outbreak, Step A Assesses Real-world Effectiveness, Safety, and Impact on Severe Disease and Mortality, While Generating Evidence for Future BDV Vaccination Strategies ERVEBO Vaccination - Ebola, Bundibugyo Virus Disease (BVD) | Phase 4 | Recruiting | Epicentre | 20000 | 2026-09-19 | 2026-10-29 |
| REVIVE (Response to the Ebola Virus Vaccine) rVSVDG-ZEBOV-GP Ebola Virus Vaccine (ERVEBO) - Ebola Virus Disease | Phase 4 | Active not recruiting | Tulane University | 40 | 2025-12-01 | 2026-06-04 |
| Safety and Immunogenicity of rVSVΔG-ZEBOV-GP Vaccination When Dosed Concurrently With mRNA COVID-19 Vaccine Booster Doses BioNTech - Pfizer COVID-19 vaccine, 1mL saline solution, rVSV∆G-ZEBOV-GP - Ebola Virus Disease, COVID-19 | Phase 4 | Unknown | University of Birmingham | 72 | 2024-10-01 | 2024-09-19 |
| International Multicenter Study of the Immunogenicity of Medicinal Product GamEvac-Combi GamEvac-Combi (vaccine), Placebo - Ebola Virus Disease, Prevention | Phase 4 | Completed | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | 2000 | 2017-08-03 | 2020-08-25 |
Hemorrhagic Fever, Ebola (4) · COVID-19 (1) · Communicable Diseases, Emerging (1)
Hemorrhagic Fevers, Viral (4) · Infections (4) · Mononegavirales Infections (4) · RNA Virus Infections (4) · Virus Diseases (4) · Communicable Diseases (1) · Coronaviridae Infections (1) · Coronavirus Infections (1) · Disease Attributes (1) · Lung Diseases (1) · Nidovirales Infections (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Pneumonia (1)
BNT162 Vaccine (1) · Saline Solution (1) · Vaccines (1)
Epicentre (1) · Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation (1) · Tulane University (1) · University of Birmingham (1)
Democratic Republic of the Congo (1) · Guinea (1) · Russia (1) · Sierra Leone (1)
Christopher Green, PhD (1) · John Schieffelin, MD (1) · Marina Rusanova, MD, PhD (1) · Sylla Ali Lathyr (1)